Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Return to the main site
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Return to the main site
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> Doctor Questions New Drug’s Use
FDAnews Drug Daily Bulletin
May 23, 2012
| Vol. 9 No. 102
Doctor Questions New Drug’s Use
A local doctor is questioning whether the German pharmaceutical giant Bayer AG illegally sells and promotes a blood-clotting prevention medicine for a use not approved by China’s State Food and Drug Administration.
East Day
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Full Issue
Experts Spar Over FDA Meeting To Re-Evaluate GSK’s Avandia
Shionogi Gets Untitled Letter After Refusing To Conduct Postmarketing Study
J&J Eyes Growth Spurt With 10 New Product Launches Planned by 2017